Summary:
- The article discusses the significant challenges and recent progress in the development of "universal" influenza vaccines that aim to provide long-term protection against multiple strains of the virus.
- It highlights the shift in research focus toward targeting the conserved "stem" region of the hemagglutinin protein, which remains stable across different flu variants, rather than the rapidly mutating "head" region.